Current Assets
Inventories
Vertex Pharmaceuticals Inventories increased by 3.7% to $1.69B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.9%, from $1.21B to $1.69B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 43.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase might suggest overproduction or weakening demand, while a decrease could indicate strong sales or potential supply chain shortages.
Detailed definition
The carrying value of raw materials, work-in-process, and finished goods awaiting sale to consumers or enterprise client...
Peer comparison
Consumer electronics firms strive for high inventory turnover to mitigate the risk of rapid technological depreciation.
Metric ID:
inventoriesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $321.62M | $333.46M | $353.10M | $338.90M | $367.70M | $388.20M | $460.60M | $535.10M | $603.50M | $688.70M | $738.80M | $813.10M | $914.60M | $1.08B | $1.21B | $1.36B | $1.50B | $1.63B | $1.69B |
| QoQ Change | — | +3.7% | +5.9% | -4.0% | +8.5% | +5.6% | +18.7% | +16.2% | +12.8% | +14.1% | +7.3% | +10.1% | +12.5% | +18.1% | +11.6% | +12.8% | +10.3% | +8.5% | +3.7% |
| YoY Change | — | — | — | — | +14.3% | +16.4% | +30.4% | +57.9% | +64.1% | +77.4% | +60.4% | +52.0% | +51.5% | +56.8% | +63.2% | +67.2% | +63.9% | +50.7% | +39.9% |
Range$321.62M – $1.69B
CAGR+44.5%
Avg YoY Growth+51.1%
Median YoY Growth+56.8%
Current Streak15 quarters growth
Inventories at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's inventories?
- Vertex Pharmaceuticals (VRTX) reported inventories of $1.69B in Q4 2025.
- How has Vertex Pharmaceuticals's inventories changed year-over-year?
- Vertex Pharmaceuticals's inventories increased by 39.9% year-over-year, from $1.21B to $1.69B.
- What is the long-term trend for Vertex Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's inventories has grown at a 43.1% compound annual growth rate (CAGR), from $280.78M to $1.69B.
- What does inventories mean?
- The value of products currently being manufactured or held in stock ready to be sold.